• 71 Hits
  • Search Condition : Filter (MeSH = Combined Modality Therapy)
Species Resource Title
Mice RBRC05737 Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
Human and Animal Cells B16/BL6(RCB2638) , B16F10(RCB2630) 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Human and Animal Cells Colon-26(RCB2657) Intravenous administration of 90Y-labeled polyoxazoline combined with tumor heating potently inhibits tumor growth in mice.
Human and Animal Cells LM8(RCB1450) TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation.
Human and Animal Cells SQ-5(RCB0110) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.
Human and Animal Cells MMAc·SF(RCB1200) Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy.
Human and Animal Cells LM8(RCB1450) Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
Human and Animal Cells LM8(RCB1450) Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Human and Animal Cells LM8(RCB1450) Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.
Human and Animal Cells L929 Bacterial exopolysaccharide based magnetic nanoparticles: a versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy.
Pathogenic eukaryotic microorganisms Cladophialophora bantiana IFM 41438 (= CBS 644.96), IFM 41439 (= CBS 101253), IFM 41436 (= CBS 642.96), IFM 41434 (= CBS 641.96 ), IFM 41437 (= CBS 643.96), IFM 4820 (= CBS 646.96), IFM 46165 (= CBS 100433), IFM 4819 (= CBS 645.96 ), IFM 41433, IFM 4807 An updated comprehensive systematic review of Cladophialophora bantiana and analysis of epidemiology, clinical characteristics, and outcome of cerebral cases.
Human and Animal Cells LM8(RCB1450) Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth.
Human and Animal Cells MCF7(RCB1904) , MDA-MB-453(RCB1192) Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7.
Human and Animal Cells LM8(RCB1450) Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody.
Human and Animal Cells TE-4(RCB2097) , TE-8(RCB2098) , TE-14(RCB2101) SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
Human and Animal Cells SCCKN(RCB0441) Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.
Human and Animal Cells HeLa , 293T(RCB2202) , HSC-2(RCB1945) , A549 microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Human and Animal Cells HeLa/Fucci2(RCB2867) Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution.
Human and Animal Cells T98G(RCB1954) , A172(RCB2530) The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status.
Human and Animal Cells SSP-25(RCB1293) , 293T(RCB2202) Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.